EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST) said it will pay a regular quarterly dividend of $0.22 per share, a routine payout that still carries signal value for investors watching whether healthcare suppliers can hold margins and cash flows amid shifting drug development cycles.
The dividend is payable February 4, 2026, to shareholders of record on January 28, 2026, the company said.
West, headquartered in Exton, manufactures injectable packaging and delivery components that are used across the pharmaceutical industry, from established drugmakers to emerging biotech firms. The company says it employs more than 10,000 people across 50 sites worldwide, including 25 manufacturing facilities, and ships more than 41 billion components and devices each year.
For 2024, West reported $2.89 billion in net sales. The company’s scale and position in the injectable supply chain have made it a closely watched name as demand grows for complex biologic medicines that often require specialized containment and delivery systems.
West trades on the New York Stock Exchange under the symbol WST and is included in the Standard & Poor’s 500 index.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.